In addition to the US FDA approved GLP-1RAs, there are GLP1/glucagon dual agonists (Cotadutide, BI 456906), GIP/GLP1 dual agonists (Tirzepatide, GIP/GLP peptide I and II), GIP/GLP1/glucagon tri-agonists (HM15211, GGG tri-agonist) and GLP1R agonists (Efpeglenatide, Rybelsus) currently in phase 1- III clinical trials for T2D, obesity, and NASH (MASH) treatments (12)
When to Consider Both The NAD/NAC combination proves most valuable during: Intense physical or mental demands Environmental stress exposure Implementation of longevity protocols Age-related cellular decline Are NAD and NAC Safe to Use
The main risks include gastrointestinal side effects (nausea, vomiting, diarrhoea), increased risk of nutritional deficiencies due to combined appetite suppression and reduced stomach capacity, and potential hypoglycaemia in patients taking certain diabetes medications
Myo-inositol Myo-inositol is a compound your body produces naturally, with a substantial body of research on its role in insulin sensitivity and hormonal balance, particularly in women
Tracking Weight Loss Progress Weight loss progress while on semaglutide should be tracked regularly, including weight, measurements, and other health indicators such as blood pressure and blood glucose levels
